DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: A meta-analysis.

Published in: PloS one (2021)

DPP-4 inhibitors may improve the mortality of patients with COVID-19 and type 2 diabetes. As few relevant studies are available, more large-scale studies need to be performed.

Keyphrases

coronavirus disease
type diabetes
cardiovascular events
case control
risk factors
cardiovascular disease
adipose tissue
respiratory syndrome coronavirus
skeletal muscle